A previous study reported that HD mice displayed improved motor functions when using selective mGluR2/3 agonists with improved to reduce mutant huntingtin aggregate formation, neuronal cell death, and microglia activation in the striatum. The gene discussed is HTT; the disease is Huntington disease.